A summary of current health news, including the disbanding of a U.S. Justice Department unit focusing on food and drug safety ...

Kenvue, the world's largest pure-play consumer health company by revenue and maker of Listerine, Nicorette, and Neutrogena, will join the UAE's first ...

Billionaire investor Daniel Loeb's hedge fund Third Point is building a stake in Kenvue , sources familiar with the matter ...

Kenvue (KVUE) stock spikes as activist investor Third Point Capital takes a stake, sparking renewed scrutiny on the J&J (JNJ) ...

These five Dividend Aristocrats have the least negligible impact from the tariffs and are ideal for passive income investors.

The Paris court of appeals ruled on Tuesday the French market watchdog must reconsider whether a mandatory buyout offer is or ...

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong ...

Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, equities analysts anticipate that Kenvue will post 1.14 EPS for the current fiscal year. Kenvue Announces Dividend ...

Kenvue Inc, a United States-based consumer health company, will deploy more resources to support medical associations and professionals to foster the management of minor ailments in China over the ...

In the latest quarter, 11 analysts provided ratings for Kenvue (NYSE:KVUE), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates ...

Kenvue was spun off from Johnson & Johnson in 2023. Essentially, the Kenvue business represents what was J&J's consumer health portfolio. While you may not be too familiar with Kenvue's name ...